Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline dose optimization in neonatal sepsis
2019-002020-33Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in neonatal sepsis, sponsored by Erasmus MC. Primary endpoint: Dose optimisation based on clinical and biochemical effects and adverse events. Started Jul 2019; status: active.
02
Drugs
pentoxifylline
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on 2019-002020-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002020-33.